PATENT CLAIM ANALYSIS

Application Number: 15888768
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates generally to immunostimulatory nucleic acids, compositions thereof and methods of using the immunostimulatory nucleic acids. In particular the invention relates to palindrome-containing immunostimulatory nucleic acids and the use of these nucleic acids in treating disease.

Claim (Index 6):
A method for treating cancer in a subject in need thereof, said method comprising the step of administering to said subject an effective amount of a P-Class immunostimulatory CpG oligonucleotide in accordance with  claim 3  in conjunction with one or more anti-cancer medicaments selected from the group consisting of chemotherapeutic agents, immunotherapeutic agents, cancer vaccines, hormone therapies, and biological response modifiers.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.61538
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15165963', '14046044', '12600368', '12442295', '10978283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8128955400918267
- 35 USC 102 Novelty (BERT): 0.5407805700794781
- Combined Prediction Score: 0.7856840430905918
- Mean Citation Score: 387.509962
- Max Citation Score: 402.00934
- Similarity Product: 303.3899573298669

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test